FDA.reportPublic FDA data

20 ML retifanlimab-dlwr 25 MG/ML Injection

RxCUI
2632985
RxNorm name
20 ML retifanlimab-dlwr 25 MG/ML Injection
Display name
20 ML retifanlimab-dlwr 25 MG/ML Injection
Full name
20 ML retifanlimab-dlwr 25 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761334Zynyzretifanlimab-dlwr351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
109648d0-d30a-42fc-8273-39cb1540a75120 ML retifanlimab-dlwr 25 MG/ML InjectionSCD16These highlights do not include all the information needed to use ZYNYZ safely and effectively. See full prescribing information for ZYNYZ . ZYNYZ ® ( retifanlimab-dlwr ) injection, for intravenous use Initial U.S. Approval: 202320260518
109648d0-d30a-42fc-8273-39cb1540a751retifanlimab-dlw 500 MG in 20 ML InjectionPSN16These highlights do not include all the information needed to use ZYNYZ safely and effectively. See full prescribing information for ZYNYZ . ZYNYZ ® ( retifanlimab-dlwr ) injection, for intravenous use Initial U.S. Approval: 202320260518
109648d0-d30a-42fc-8273-39cb1540a751retifanlimab-dlw 500 MG per 20 ML InjectionSY16These highlights do not include all the information needed to use ZYNYZ safely and effectively. See full prescribing information for ZYNYZ . ZYNYZ ® ( retifanlimab-dlwr ) injection, for intravenous use Initial U.S. Approval: 202320260518